On Friday, Pulmonx Corp (NASDAQ: LUNG) opened at On Friday, higher 6.73% from the last session, before settling in for the closing price of $2.97. Price fluctuations for LUNG have ranged from $2.83 to $9.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 20.78% over the past five years. Company’s average yearly earnings per share was noted -6.92% at the time writing. With a float of $35.22 million, this company’s outstanding shares have now reached $40.25 million.
Let’s look at the performance matrix of the company that is accounted for 291 employees. In terms of profitability, gross margin is 73.58%, operating margin of -66.0%, and the pretax margin is -64.76%.
Pulmonx Corp (LUNG) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Pulmonx Corp is 12.26%, while institutional ownership is 85.88%. The most recent insider transaction that took place on Jun 05 ’25, was worth 71,362. In this transaction Director of this company bought 23,321 shares at a rate of $3.06, taking the stock ownership to the 117,231 shares. Before that another transaction happened on Jun 02 ’25, when Company’s PRESIDENT AND CEO sold 9,923 for $3.13, making the entire transaction worth $31,059. This insider now owns 366,115 shares in total.
Pulmonx Corp (LUNG) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.92% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.76% during the next five years compared to -19.80% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Check out the current performance indicators for Pulmonx Corp (LUNG). In the past quarter, the stock posted a quick ratio of 4.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.45, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.39 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Pulmonx Corp (NASDAQ: LUNG) saw its 5-day average volume 0.51 million, a positive change from its year-to-date volume of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 35.37%. Additionally, its Average True Range was 0.34.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 5.20%, which indicates a significant decrease from 46.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.07% in the past 14 days, which was lower than the 90.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.44, while its 200-day Moving Average is $6.36. Nevertheless, the first resistance level for the watch stands at $3.45 in the near term. At $3.74, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.91. If the price goes on to break the first support level at $2.99, it is likely to go to the next support level at $2.82. Assuming the price breaks the second support level, the third support level stands at $2.53.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
There are currently 40,258K shares outstanding in the company with a market cap of 127.62 million. Presently, the company’s annual sales total 83,790 K according to its annual income of -56,390 K. Last quarter, the company’s sales amounted to 22,540 K and its income totaled -14,450 K.
